Dr. Arvind Parmar, Dr. Giancarlo Pascali and Dr. Orazio Vittorio of CCI led the development of a new PET imaging protocol using small quantity of the radioactive form of copper chloride that measured in vivo neuroblastoma tumor response to the drug Dextran-Catechin in a pre-clinical laboratory model.  {read more here}

In the study, Dr. Eidelberg and his team analyzed metabolic PET scans from 15 Parkinson’s disease patients who received the gene therapy and 20 who were randomized to sham surgery and then rescanned six and 12 months after surgery. What they found was that those who received the gene therapy started to form new brain connections, which matured by the end of the 12-month study. {read more here}

Researchers from Brazil found that the hybrid modality outperformed more conventional imaging options by detecting more lesions and better assessing the spread of disease. PET/MRI also offered “tolerable scan times” and helped distinguish between high- and low-risk rectal cancer patients. {read more here}

By performing myocardial perfusion imaging (MPI) with cardiac FDG-PET before revascularization, clinicians can better assess the benefits of that procedure and predict near-term outcomes for patients with coronary artery disease and left ventricular dysfunction, according to a study presented on Sunday at RSNA 2018. {read more here}